{"name":"Inventera Inc.","slug":"inventera-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"NEMO-103 Injection","genericName":"NEMO-103 Injection","slug":"nemo-103-injection","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"NEMO-103 Injection","genericName":"NEMO-103 Injection","slug":"nemo-103-injection","phase":"phase_3","mechanism":"NEMO-103 Injection's mechanism is not publicly available.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNRmFwMm81UjdSd0hRSVc3eUhaekt0Um54Tlo1ckVPMEJBMnhkRENNS0hUU0ZUVGJSdk9fWUcxVzJpYWRXLU1VS3R2Wkg4U2syTm1zUl9VLVZRbUVFenhvVUZhVWgyY0dQOEhQQkxWLVNBTWVIZHF2NnlHTlRvbjgyYtIBlAFBVV95cUxPd3NSSzgwNVpqZEUzNHlydTZvY3VlYjhrTDlMSWhjTEVZUHd3SFZtUmhDSklaNTBCalZOc19nMGQ4UUNmVVdwbzhFNVE2TjFad09uTEVZaDBjc2VCY1dSN0Jpc3NLNXl1NlVfbkZIbjd0OXZmLThhVklkSGpqbW4yTjZaQWowSlNuWVZyeWxENURqel85?oc=5","date":"2026-03-24","type":"regulatory","source":"Chosunbiz","summary":"Inventera draws record retail demand as KOSDAQ IPO nears in South Korea - CHOSUNBIZ - Chosunbiz","headline":"Inventera draws record retail demand as KOSDAQ IPO nears in South Korea - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE4xRXVIclIzbnk5UXAzcHg4OUpDdkhTbkJMNGhNWWc4d1pGdWU3S2ZHZVVzWXJMVnktTy1SMHhvd2t4a2ZFeHBwUXNUcnhHRTZ1NS1nNjBpdE1RRkYwTU5XMVByaTQzQnNwOEotMjdR0gFyQVVfeXFMTjNxd2h2T0tUSVhYWTk1MUE0RWIxYXc0OUNOczdjam5GYTRSSU15cGFrcGs0OGRkelNwbEhvMFM1YlJDRXNHOVhwdDZLeDhGMzRHY1NMNHVjQUd5SnRuUmhfb2FOQkwzQ1V3N2tWQmVfc0xB?oc=5","date":"2026-03-16","type":"pipeline","source":"koreabiomed.com","summary":"Inventera eyes Kosdaq debut with disease-specific MRI agent - koreabiomed.com","headline":"Inventera eyes Kosdaq debut with disease-specific MRI agent","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPeUV3TmxadFJkRF9IUG5vcFVTckpldV9BUHU3eGNEVngtVjlndUJuUzhTbjZHVDBqWVdUZzAweUpjY1FlUWk5MjJKZUVDc2dQaUN6MVZlWnY3M2U5ZDNrWW9DWE9sdlQ0bTJHS3RXdGQtbW9yaFpqTEt2SzZwMDNJMtIBlAFBVV95cUxOX25GU1l1X2hOdlN1RS10aTl6Z0YxdnR4Z1p5SDM0MHlVclRhTmttWDNWUEVoX3hNNUhRY096OFVadUF2RDd0WlpGbzBMWkRBR0FBZmhsVmpzUDdpb1lXb3A3Y1NjQlFYTjR6VnpxOVZuNHRSemJobXMxYnlhaFF2eS01ZWNDX0h1eFBEeXdEUE1ySTE5?oc=5","date":"2026-03-16","type":"regulatory","source":"Chosunbiz","summary":"Inventera targets KOSDAQ listing as iron MRI agent nears approval in Korea - CHOSUNBIZ - Chosunbiz","headline":"Inventera targets KOSDAQ listing as iron MRI agent nears approval in Korea - CHOSUNBIZ","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPRWx2Vm0yUXhib2M1ajR3czRkaHJnZ1diMWlXSThsS3doend0akdBN3lFM1BTU2lUWXMyTFVQM3JEUmN5ck9oY0QtSmxudEJwU193OTIyVFA5WmxlRTVrNU1zZkk2eGpFaE5fM1RPRERQOW85RTZ4R0diRWVBQjZTb2NJS01CajNGN1VxdHhVdGU3N1NKbnhTdngzRnptWDBEaVlB?oc=5","date":"2026-02-02","type":"pipeline","source":"en.sedaily.com","summary":"MRI Contrast Agent Developer Inventera Files for KOSDAQ IPO - en.sedaily.com","headline":"MRI Contrast Agent Developer Inventera Files for KOSDAQ IPO","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-08","type":"pipeline","source":"The Korea Times","summary":"Tech-driven listings fuel expectations for IPO upcycle in Korea - The Korea Times","headline":"Tech-driven listings fuel expectations for IPO upcycle in Korea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBNTWlNaVVRRW8zOFNxNkxOMHQxRW1wWk1KSDhGR1FkNUNlbG8tU1ZpMjBRRkIxVlZSS2VQRVp1N1Z2ZHhlQ0JFZUdlMHlMQ21HeGRlY01ZUUk0RUxoQ1Q4MWRKLXZIR25Ta3NBa1Z30gFyQVVfeXFMTjJCSlZJdVZNdnhJM2xYU0E1ZGFmYWVwQWpQbzRfbzMxSGhEUFVVdjk5SmFRNGVMX2VNZElOTGdvWXFxUElsZmtpTU1iLS01eE84Y1pvTkx0MGRNcjA4dmRIVHVhcDBMNFU2RFZFblRIM0lB?oc=5","date":"2025-01-17","type":"deal","source":"koreabiomed.com","summary":"Inventera and LG Chem partner for next-gen MRI contrast agent API production - koreabiomed.com","headline":"Inventera and LG Chem partner for next-gen MRI contrast agent API production","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}